dalteparin has been researched along with Fatty Liver, Nonalcoholic in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bos, S | 1 |
| Potze, W | 1 |
| Siddiqui, MS | 1 |
| Boyett, SL | 1 |
| Adelmeijer, J | 1 |
| Daita, K | 1 |
| Lisman, T | 1 |
| Sanyal, AJ | 1 |
1 other study available for dalteparin and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Changes of in vitro potency of anticoagulant drugs are similar between patients with cirrhosis due to alcohol or non-alcoholic fatty liver disease.
Topics: Adult; Alcoholism; Anticoagulants; Dabigatran; Enoxaparin; Female; Hemostasis; Humans; Liver Cirrhos | 2017 |